Millennium Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Millennium Management’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,974	Closed	-$15K	–	7489
2022 Q3	$15K	Buy	1,974 +89	+5%	+$1.08K	﹤0.01%	6555
2022 Q2	$23K	Sell	1,885 -406	-18%	-$3.81K	﹤0.01%	6461
2022 Q1	$38K	Buy	+2,291	New	+$73.5K	﹤0.01%	6480
2021 Q4	–	Sell	-1,310	Closed	-$90K	–	7648
2021 Q3	$90K	Buy	+1,310	New	+$93.7K	﹤0.01%	6472
2020 Q2	–	Sell	-89	Closed	-$5K	–	4761
2020 Q1	$5K	Buy	+89	New	+$8.71K	﹤0.01%	3768
2019 Q4	–	Sell	-250	Closed	-$30K	–	4763
2019 Q3	$30K	Sell	250 -52	-17%	-$10.5K	﹤0.01%	4075
2019 Q2	$90K	Buy	302 +114	+61%	+$47.5K	﹤0.01%	3904
2019 Q1	$85K	Sell	188 -142	-43%	-$62.2K	﹤0.01%	3862
2018 Q4	$151K	Buy	+330	New	+$205K	﹤0.01%	3469
2018 Q3	–	Sell	-437	Closed	-$257K	–	4401
2018 Q2	$257K	Buy	+437	New	+$285K	﹤0.01%	3456
2017 Q4	–	Sell	-161	Closed	-$49K	–	4183
2017 Q3	$49K	Buy	+161	New	+$61.1K	﹤0.01%	3415

Other funds holding HTGM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HWM

HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TWA

TCI Wealth Advisors Tucson, Arizona $1.88B AUM 21.09% 1-Year Est. Return

Millennium Management's HTGM Position: Q4 2022 in Review

Millennium Management sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q4 2022, closing a stake of 1,974 shares — an estimated $15K sold.

Millennium Management first reported a position in HTGM in Q3 2017 and held it in 11 quarters. The position peaked at $257K in Q2 2018. 10 funds tracked by Wall St. Rank hold HTGM as of Q4 2022.

Millennium Management reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Millennium Management sold 1,974 HTG Molecular Diagnostics, Inc. Common Stock shares in Q4 2022, an estimated $15K.
Millennium Management first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q3 2017 and held it in 11 quarters.
Millennium Management's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $257K in Q2 2018.
10 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.